Search Result

Results for "

Ubiquinone

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ADC Payload (1) Akt (1) Antibiotic (1) Apoptosis (6) Autophagy (1) Bacterial (3) Bcl-2 Family (1) Calcium Channel (4) Caspase (1) COX (1) Dihydroorotate Dehydrogenase (1) DNA/RNA Synthesis (1) EGFR (1) Endogenous Metabolite (16) Environmental Pollutants (2) Ferroptosis (4) Fungal (9) Indoleamine 2,3-Dioxygenase (IDO) (1) Interleukin Related (1) Isotope-Labeled Compounds (5) Keap1-Nrf2 (1) Mitochondrial Metabolism (13) MMP (1) mTOR (1) NADPH Oxidase (1) NF-κB (1) NO Synthase (1) Oxidative Phosphorylation (1) Parasite (1) PARP (1) Reactive Oxygen Species (ROS) (7) Reference Standards (5) Succinate Dehydrogenase (3) TNF Receptor (1) TRP Channel (5)
By Research Areas:	Cancer (13) Cardiovascular Disease (2) Infection (14) Inflammation/Immunology (14) Metabolic Disease (8) Neurological Disease (12)

By Targets:

ADC Payload (1)

Akt (1)

Antibiotic (1)

Apoptosis (6)

Autophagy (1)

Bacterial (3)

Bcl-2 Family (1)

Calcium Channel (4)

Caspase (1)

COX (1)

Dihydroorotate Dehydrogenase (1)

DNA/RNA Synthesis (1)

EGFR (1)

Endogenous Metabolite (16)

Environmental Pollutants (2)

Ferroptosis (4)

Fungal (9)

Indoleamine 2,3-Dioxygenase (IDO) (1)

Interleukin Related (1)

Isotope-Labeled Compounds (5)

Keap1-Nrf2 (1)

Mitochondrial Metabolism (13)

MMP (1)

mTOR (1)

NADPH Oxidase (1)

NF-κB (1)

NO Synthase (1)

Oxidative Phosphorylation (1)

Parasite (1)

PARP (1)

Reactive Oxygen Species (ROS) (7)

Reference Standards (5)

Succinate Dehydrogenase (3)

TNF Receptor (1)

TRP Channel (5)

By Research Areas:

Cancer (13)

Cardiovascular Disease (2)

Infection (14)

Inflammation/Immunology (14)

Metabolic Disease (8)

Neurological Disease (12)

Inhibitors & Agonists

Biochemical Assay Reagents

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-N0111

Coenzyme Q10 Maximum Cited Publications 14 Publications Verification CoQ10; Ubiquinone-10; Ubidecarenone	Endogenous Metabolite Reactive Oxygen Species (ROS) Ferroptosis	Neurological Disease Metabolic Disease Inflammation/Immunology Cancer
Coenzyme Q10 is an essential cofactor of the electron transport chain and a potent antioxidant agent.

HY-113449

Ubiquinone-1	Endogenous Metabolite NADPH Oxidase	Metabolic Disease
Ubiquinone-1 is an intermediate in the synthesis of Coenzyme Q. Ubiquinone-1 can be reduced by NADPH oxidase, hepatoma cells, Ascorbic acid (HY-B0166) .

HY-119976

Boscalid 1 Publications Verification	Environmental Pollutants Apoptosis Fungal Mitochondrial Metabolism Succinate Dehydrogenase	Infection
Boscalid is a succinate dehydrogenase (SDHI) inhibitor with antifungal activity. Boscalid binds to the ubiquinone-binding site of fungal mitochondrial complex II, blocks ATP production and aerobic respiration, exhibits good control efficacy against a variety of plant fungal diseases including gray mold, sclerotinia rot and powdery mildew, and is widely used for disease control in agriculture. Boscalid induces apoptosis, altered lipid metabolism, mitochondrial dysfunction, respiratory impairment, oxidative stress, ROS accumulation and neurodevelopmental disorders in zebrafish. Boscalid reduces foraging ability, shortens median death time and causes chronic toxicity in exposed honeybees. Boscalid also possesses genotoxicity, cytotoxicity, elevated mitochondrial superoxide levels and early-stage apoptosis .

HY-101415

Coenzyme Q9 1 Publications Verification Ubiquinone Q9; CoQ9; Ubiquinone 9	Apoptosis Endogenous Metabolite	Cardiovascular Disease
Coenzyme Q9 (Ubiquinone Q9), the major form of ubiquinone in rodents, is an amphipathic molecular component of the electron transport chain that functions as an endogenous antioxidant. Coenzyme Q9 attenuates the diabetes-induced decreases in antioxidant defense mechanisms. Coenzyme Q9 improves left ventricular performance and reduces myocardial infarct size and cardiomyocyte apoptosis .

HY-113037C

Farnesyl pyrophosphate ammonium Farnesyl diphosphate ammonium	TRP Channel Endogenous Metabolite Calcium Channel	Neurological Disease Inflammation/Immunology Cancer
Farnesyl pyrophosphate (Farnesyl diphosphate) ammonium is a metabolic intermediate in the mevalonate (MVA) pathway. It is a TRP channel (TRPM2) agonist that triggers Ca2+ influx and cell death. Farnesyl pyrophosphate ammonium is a key branch substrate for cholesterol synthesis, ubiquinone synthesis, protein farnesylation, and geranylgeranyl pyrophosphate (GGPP) synthesis. Farnesyl pyrophosphate ammonium is used in research on cerebral ischemia, neurodegenerative diseases, pancreatic cancer, inflammation, and autoimmune diseases .

HY-W016412

Coenzyme Q0 2 Publications Verification CoQ0	Apoptosis Autophagy EGFR Akt mTOR Caspase Bcl-2 Family Reactive Oxygen Species (ROS) PARP COX NO Synthase TNF Receptor Interleukin Related MMP NF-κB	Neurological Disease Inflammation/Immunology Cancer
Coenzyme Q0 (CoQ0) is a potent, oral active ubiquinone compound can be derived from Antrodia cinnamomea. Coenzyme Q0 induces apoptosis and autophagy, suppresses of HER-2/AKT/mTOR signaling to potentiate the apoptosis and autophagy mechanisms. Coenzyme Q0 regulates NFκB/AP-1 activation and enhances Nrf2 stabilization in attenuation of inflammation and redox imbalance. Coenzyme Q0 has anti-angiogenic activity through downregulation of MMP-9/NF-κB and upregulation of HO-1 signaling .

HY-114936

Piericidin A 5 Publications Verification AR-054	Bacterial ADC Payload Antibiotic Mitochondrial Metabolism	Infection Neurological Disease Cancer
Piericidin A (AR-054) is a natural mitochondrial *NADH-ubiquinone* oxidoreductase (complex I) inhibitor. Piericidin A is a potent neurotoxin and inhibits mitochondrial respiration by disrupting the electron transport system through its action on NADH-ubiquinone reductase. Piericidin A is also a potential quorum-sensing** inhibitor that suppresses the expression of the virulence genes of Erwinia carotovora subsp. atroseptica (Eca). Piericidin A is an ADC cytotoxin and has anti-bacterial, anticancer, insecticidal activity .

HY-B2004

Thifluzamide	Environmental Pollutants Fungal Mitochondrial Metabolism	Infection
Thifluzamide is a fungicide that inhibits fungal respiration by blocking the ubiquinone-binding site in mitochondrial complex II. Thifluzamide exhibits significant activity against Basidiomycota pathogens (such as Rhizoctonia cerealis, Ustilago and Puccinia genera) and is commonly used in studies on wheat sharp eyespot. Thifluzamide displays a dual mechanism in regulating lipid metabolism: it reduces fatty acid synthase activity to inhibit endogenous fatty acid synthesis, and increases carnitine palmitoyltransferase-I activity to accelerate fatty acid β-oxidation, thereby reducing total cholesterol and triglyceride levels in the liver. Thifluzamide also induces hepatotoxicity in zebrafish models and carries a risk of developmental toxicity. Thifluzamide inhibition of Rhizoctonia cerealis may result in low to moderate levels of drug resistance, leading to the generation of stable drug-resistant mutants .

HY-121134

Decylubiquinone 1 Publications Verification	Reactive Oxygen Species (ROS)	Neurological Disease Cancer
Decylubiquinone is an analog of ubiquinone (coenzyme Q₁₀). Decylubiquinone blocks reactive oxygen species (ROS) production in response to glutathione depletion and inhibits activation of the mitochondrial permeability transition .

HY-113037

(E/Z)-Farnesyl pyrophosphate (E/Z)-Farnesyl diphosphate	TRP Channel Endogenous Metabolite	Neurological Disease
(E/Z)-Farnesyl pyrophosphate ((E/Z)-Farnesyl diphosphate), a 15-carbon isoprenoid, is a metabolic intermediate of the mevalonate (MVA) pathway. (E/Z)-Farnesyl pyrophosphate is a TRPM2 (TRP Channel) agonist, activates TRPM2 opening for ion influx. (E/Z)-Farnesyl pyrophosphate is a key branch substrate for cholesterol synthesis, ubiquinones synthesis, protein farnesylation decoration, and geranyl-geranyl pyrophosphate (GGPP) synthesis .

HY-N0111S2

Coenzyme Q10-d9 CoQ10-d₉; Ubiquinone-10-d₉	Isotope-Labeled Compounds Endogenous Metabolite Reactive Oxygen Species (ROS) Ferroptosis	Neurological Disease Metabolic Disease Inflammation/Immunology Cancer
Coenzyme Q10-d₉ is the deuterium labeled Coenzyme Q10. Coenzyme Q10 is an essential cofactor of the electron transport chain and a potent antioxidant agent.

HY-19893

Antroquinonol (+)-Antroquinonol	Keap1-Nrf2	Inflammation/Immunology Cancer
Antroquinonol ((+)-Antroquinonol), a ubiquinone derivative from the mushroom Antrodia camphorata, has hepatoprotective, anti-inflammatory, and anti-cancer effects . Antroquinonol can be used for the research of colon cancer . Antroquinonol reduces oxidative stress by enhancing the Nrf2 signaling pathway and inhibits inflammation and sclerosis in focal segmental glomerulosclerosis mice .

HY-N0111S

Coenzyme Q10-d6 CoQ10-d₆; Ubiquinone-10-d₆	Isotope-Labeled Compounds Endogenous Metabolite Reactive Oxygen Species (ROS) Ferroptosis	Neurological Disease Metabolic Disease Inflammation/Immunology Cancer
Coenzyme Q10-d₆ is deuterium labeled Coenzyme Q10. Coenzyme Q10 is an essential cofactor of the electron transport chain and a potent antioxidant agent.

HY-129605

Ferulenol	Oxidative Phosphorylation Mitochondrial Metabolism	Infection
Ferulenol, a sesquiterpene prenylated coumarin derivative, specifically inhibits succinate ubiquinone reductase at the level of the ubiquinonecycle. Ferulenol shows good antimycobacterial activity and haemorrhagic action .

HY-133033

COQ7-IN-1	Mitochondrial Metabolism	Metabolic Disease
COQ7-IN-1, a highly potent inhibitor of human coenzyme Q (COQ7), interferes with *ubiquinone* (UQ) synthesis. COQ7-IN-1 does not disturb physiological cell growth of human normal culture cells. COQ7-IN-1 can be used for the research of the balance between UQ supplementation pathways: de novo UQ synthesis and extracellular UQ uptake .

HY-N0111R

Coenzyme Q10 (Standard) CoQ10 (Standard); Ubiquinone-10 (Standard); Ubidecarenone (Standard)	Reference Standards Endogenous Metabolite Reactive Oxygen Species (ROS) Ferroptosis	Neurological Disease Metabolic Disease Inflammation/Immunology Cancer
Coenzyme Q10 (Standard) is the analytical standard of Coenzyme Q10. This product is intended for research and analytical applications. Coenzyme Q10 is an essential cofactor of the electron transport chain and a potent antioxidant agent.

HY-113037CS

Farnesyl pyrophosphate-d2 triammonium Farnesyl diphosphate-d2 triammonium	Isotope-Labeled Compounds TRP Channel Endogenous Metabolite Calcium Channel	Neurological Disease Inflammation/Immunology Cancer
Farnesyl pyrophosphate-d₂ (Farnesyl diphosphate-d₂) triammonium is a deuterium labeled Farnesyl pyrophosphate triammonium (HY-113037C). Farnesyl pyrophosphate ammonium is a metabolic intermediate in the mevalonate (MVA) pathway. It is a TRP channel (TRPM2) agonist that triggers Ca2+ influx and cell death. Farnesyl pyrophosphate ammonium is a key branch substrate for cholesterol synthesis, ubiquinone synthesis, protein farnesylation, and geranylgeranyl pyrophosphate (GGPP) synthesis. Farnesyl pyrophosphate ammonium is used in research on cerebral ischemia, neurodegenerative diseases, pancreatic cancer, inflammation, and autoimmune diseases.

HY-101415R

Coenzyme Q9 (Standard) Ubiquinone Q9 (Standard); CoQ9 (Standard); Ubiquinone 9 (Standard)	Reference Standards Apoptosis Endogenous Metabolite	Cardiovascular Disease
Coenzyme Q9 (Standard) is the analytical standard of Coenzyme Q9. This product is intended for research and analytical applications. Coenzyme Q9 (Ubiquinone Q9), the major form of ubiquinone in rodents, is an amphipathic molecular component of the electron transport chain that functions as an endogenous antioxidant. Coenzyme Q9 attenuates the diabetes-induced decreases in antioxidant defense mechanisms. Coenzyme Q9 improves left ventricular performance and reduces myocardial infarct size and cardiomyocyte apoptosis .

HY-N9610

Coenzyme Q6 Ubiquinone 30	Endogenous Metabolite	Inflammation/Immunology
Coenzyme Q6 (Ubiquinone 30) is an isoprenylated benzoquinone lipid. Coenzyme Q6 exhibits functions in respiratory electron transport and as a lipid antioxidant. Coenzyme Q6 also has antioxidant effects, which can prevent the production of free radicals and oxidative damage .

HY-113037B

Farnesyl pyrophosphate Farnesyl diphosphate	TRP Channel Endogenous Metabolite Calcium Channel	Neurological Disease Inflammation/Immunology Cancer
Farnesyl pyrophosphate is a metabolic intermediate in the mevalonate (MVA) pathway. It is a TRP channel (TRPM2) agonist that triggers Ca2+ influx and cell death. Farnesyl pyrophosphate is a key branch substrate for cholesterol synthesis, ubiquinone synthesis, protein farnesylation, and geranylgeranyl pyrophosphate (GGPP) synthesis. Farnesyl pyrophosphate is used in research on cerebral ischemia, neurodegenerative diseases, pancreatic cancer, inflammation, and autoimmune diseases.

HY-139205

BMT-297376	Indoleamine 2,3-Dioxygenase (IDO) Mitochondrial Metabolism	Inflammation/Immunology
BMT-297376 is an optimized derivative of Linrodostat (HY-101560). BMT-297376 inhibits IDO1 and the ubiquinone (Q) site of mitochondrial respiratory chain complex I. BMT-297376 is suitable for tumor immunology-related research .

HY-157744

*Coumarin–quinone* conjugate**	Mitochondrial Metabolism	Cancer
Coumarin–quinone conjugate is a fluorescent substrate for NADH:ubiquinone oxidoreductases which consists of a coumarin fluorophore and a ubiquinone analog. Coumarin–quinone conjugate can be used to measure the kinetic parameters of AIFM2/FSP1 for researches such as ferroptosis .

HY-113037AS

Farnesyl pyrophosphate-d6 Farnesyl diphosphate-d₆	Isotope-Labeled Compounds TRP Channel Endogenous Metabolite Calcium Channel	Neurological Disease Inflammation/Immunology Cancer
Farnesyl pyrophosphate-d₆ (Farnesyl diphosphate-d₆) is a deuterium labeled Farnesyl pyrophosphate (HY-113037B). Farnesyl pyrophosphate is a metabolic intermediate in the mevalonate (MVA) pathway. It is a TRP channel (TRPM2) agonist that triggers Ca2+ influx and cell death. Farnesyl pyrophosphate is a key branch substrate for cholesterol synthesis, ubiquinone synthesis, protein farnesylation, and geranylgeranyl pyrophosphate (GGPP) synthesis. Farnesyl pyrophosphate is used in research on cerebral ischemia, neurodegenerative diseases, pancreatic cancer, inflammation, and autoimmune diseases.

HY-N9680

Coenzyme Q8 Ubiquinone 8	Endogenous Metabolite Bacterial	Infection Inflammation/Immunology
Coenzyme Q8 (Ubiquinone 8) is an isoprenoid quinone that mediates electron transfer within the aerobic respiratory chain and reduces oxidative stress. Coenzyme Q8 maintains bacterial respiratory function and enhances host resistance to bacterial infection. Coenzyme Q8 stimulates macrophage phagocytosis and increases antibody-producing cells. Coenzyme Q8 can be used in infectious disease research .

HY-159118

PC-Qz1	Bacterial	Infection
PC-Qz1 is a mitochondrial *NADH-ubiquinone* oxidoreductase (complex I) inhibitor with an IC₅₀ of 470 nM. PC-Qz1 has antibacterial** activity .

HY-178033

Antileishmanial agent-35	Parasite Mitochondrial Metabolism Reactive Oxygen Species (ROS)	Infection
Antileishmanial agent-35 (Compound 6) is an antileishmanial agent with an IC₅₀ of 0.29μM for promastigotes of Leishmania amazonensis. Antileishmanial agent-35 significantly decreases the mitochondrial membrane potential and ATP levels, and further increases the production of ROS by a blockage in the electron transport chain, where ubiquinone intervenes. Antileishmanial agent-35 can be used for cutaneous leishmaniases research .

HY-N11884

Ubiquinone Q3	Endogenous Metabolite	Inflammation/Immunology
Ubiquinone Q3 is an isoprenoid-chain ubiquinone homologue found in Saccharomyces cerevisiae, Escherichia coli, and Rhodospirillum rubrum. Ubiquinone Q3 has antioxidant activity and traps lipid peroxyl radicals .

HY-124408

Mepronil	Fungal	Infection
Mepronil, a compound belonging to the carboxyamine group of fungicides, has a particularly strong bactericidal effect on basidiomycete fungi. Mepronil acts as a single point inhibitor of the *succinate ubiquinone* reductase or succinate dehydrogenase complex**. Mepronil can be used in the study of cross resistance and biological infection .

HY-135618

DHODH-IN-3	Dihydroorotate Dehydrogenase DNA/RNA Synthesis	Infection
DHODH-IN-3 (compound 3) is a potent inhibitor of Human Dihydroorotate Dehydrogenases (HsDHODH) with an IC₅₀ value of 261 nM. DHODH-IN-3 binds to the the ubiquinone binding cavities in DHODH with a K_i ^app of 32 nM. DHODH-IN-3 has the potential for malaria treatment .

HY-146036

NADH-IN-1	Endogenous Metabolite	Metabolic Disease
NADH-IN-1 has *NADH:ubiquinone* oxidoreductase inhibitory activity with an IC₅₀** value of 27 μM. NADH-IN-1 can effectively stimulate glucose uptake in vitro. NADH-IN-1 is readily metabolised by the liver. NADH-IN-1 can be used for researching diabetes .

HY-124408R

Mepronil (Standard)	Reference Standards Fungal	Infection
Mepronil (Standard) is the analytical standard of Mepronil. This product is intended for research and analytical applications. Mepronil, a compound belonging to the carboxyamine group of fungicides, has a particularly strong bactericidal effect on basidiomycete fungi. Mepronil acts as a single point inhibitor of the succinate ubiquinone reductase or succinate dehydrogenase complex. Mepronil can be used in the study of cross resistance and biological infection .

HY-138429

COQ7-IN-2 1 Publications Verification	Mitochondrial Metabolism	Metabolic Disease
COQ7-IN-2 (compound 12) is an inhibitor of COQ7, witn IC₅₀ values of 7.3 μM and 15.4 μM for DMQ₁₀ and UQ₁₀ accumulation, respectively .

HY-119976S

Boscalid-d4	Isotope-Labeled Compounds Apoptosis Fungal Mitochondrial Metabolism Succinate Dehydrogenase	Others
Boscalid-d₄ is the deuterium labeled Boscalid. Boscalid is a succinate dehydrogenase (SDHI) inhibitor with antifungal activity. Boscalid binds to the ubiquinone-binding site of fungal mitochondrial complex II, blocks ATP production and aerobic respiration, exhibits good control efficacy against a variety of plant fungal diseases including gray mold, sclerotinia rot and powdery mildew, and is widely used for disease control in agriculture. Boscalid induces apoptosis, altered lipid metabolism, mitochondrial dysfunction, respiratory impairment, oxidative stress, ROS accumulation and neurodevelopmental disorders in zebrafish. Boscalid reduces foraging ability, shortens median death time and causes chronic toxicity in exposed honeybees. Boscalid also possesses genotoxicity, cytotoxicity, elevated mitochondrial superoxide levels and early-stage apoptosis .

HY-119976R

Boscalid (Standard)	Reference Standards Apoptosis Fungal Mitochondrial Metabolism Succinate Dehydrogenase	Infection
Boscalid (Standard) is the analytical standard of Boscalid. This product is intended for research and analytical applications. Boscalid is a succinate dehydrogenase (SDHI) inhibitor with antifungal activity. Boscalid binds to the ubiquinone-binding site of fungal mitochondrial complex II, blocks ATP production and aerobic respiration, exhibits good control efficacy against a variety of plant fungal diseases including gray mold, sclerotinia rot and powdery mildew, and is widely used for disease control in agriculture. Boscalid induces apoptosis, altered lipid metabolism, mitochondrial dysfunction, respiratory impairment, oxidative stress, ROS accumulation and neurodevelopmental disorders in zebrafish. Boscalid reduces foraging ability, shortens median death time and causes chronic toxicity in exposed honeybees. Boscalid also possesses genotoxicity, cytotoxicity, elevated mitochondrial superoxide levels and early-stage apoptosis .

HY-B2004R

Thifluzamide (Standard)	Reference Standards Fungal Mitochondrial Metabolism	Infection
Thifluzamide (Standard) is the analytical standard of Thifluzamide. This product is intended for research and analytical applications. Thifluzamide is a fungicide that inhibits fungal respiration by blocking the ubiquinone-binding site in mitochondrial complex II. Thifluzamide exhibits significant activity against Basidiomycota pathogens (such as Rhizoctonia cerealis, Ustilago and Puccinia genera) and is commonly used in studies on wheat sharp eyespot. Thifluzamide displays a dual mechanism in regulating lipid metabolism: it reduces fatty acid synthase activity to inhibit endogenous fatty acid synthesis, and increases carnitine palmitoyltransferase-I activity to accelerate fatty acid β-oxidation, thereby reducing total cholesterol and triglyceride levels in the liver. Thifluzamide also induces hepatotoxicity in zebrafish models and carries a risk of developmental toxicity. Thifluzamide inhibition of Rhizoctonia cerealis may result in low to moderate levels of drug resistance, leading to the generation of stable drug-resistant mutants .

HY-W725177

Inpyrfluxam	Fungal Mitochondrial Metabolism	Infection
Inpyrfluxam is a succinate dehydrogenase (SDH) inhibitor. Inpyrfluxam targets the ubiquinone binding pocket of mitochondrial SDH complex subunits ViSDHB, ViSDHC, ViSDHD, interfering with cellular respiration. Inpyrfluxam inhibits conidial germination and mycelial growth of Venturia inaequalis in vitro. Inpyrfluxam can be used for the research of apple scab .

HY-165191

LY214352	Fungal	Infection
LY214352 is an antifungal agent that targets dihydroorotate dehydrogenase (DHO-DH). LY214352 exhibits antifungal activity against Aspergillus nidulans and agriculturally important ascomycete fungi. LY214352 can be used in studies related to grape gray mold, apple scab, and fungal infections caused by ascomycetes .

Cat. No.	Product Name	Type

HY-119976

Boscalid 1 Publications Verification	Biochemical Assay Reagents
Boscalid is a succinate dehydrogenase (SDHI) inhibitor with antifungal activity. Boscalid binds to the ubiquinone-binding site of fungal mitochondrial complex II, blocks ATP production and aerobic respiration, exhibits good control efficacy against a variety of plant fungal diseases including gray mold, sclerotinia rot and powdery mildew, and is widely used for disease control in agriculture. Boscalid induces apoptosis, altered lipid metabolism, mitochondrial dysfunction, respiratory impairment, oxidative stress, ROS accumulation and neurodevelopmental disorders in zebrafish. Boscalid reduces foraging ability, shortens median death time and causes chronic toxicity in exposed honeybees. Boscalid also possesses genotoxicity, cytotoxicity, elevated mitochondrial superoxide levels and early-stage apoptosis .

Boscalid

1 Publications Verification

Biochemical Assay Reagents

Boscalid is a succinate dehydrogenase (SDHI) inhibitor with antifungal activity. Boscalid binds to the ubiquinone-binding site of fungal mitochondrial complex II, blocks ATP production and aerobic respiration, exhibits good control efficacy against a variety of plant fungal diseases including gray mold, sclerotinia rot and powdery mildew, and is widely used for disease control in agriculture. Boscalid induces apoptosis, altered lipid metabolism, mitochondrial dysfunction, respiratory impairment, oxidative stress, ROS accumulation and neurodevelopmental disorders in zebrafish. Boscalid reduces foraging ability, shortens median death time and causes chronic toxicity in exposed honeybees. Boscalid also possesses genotoxicity, cytotoxicity, elevated mitochondrial superoxide levels and early-stage apoptosis .

HY-W016412

Coenzyme Q0 2 Publications Verification CoQ0	Biochemical Assay Reagents
Coenzyme Q0 (CoQ0) is a potent, oral active ubiquinone compound can be derived from Antrodia cinnamomea. Coenzyme Q0 induces apoptosis and autophagy, suppresses of HER-2/AKT/mTOR signaling to potentiate the apoptosis and autophagy mechanisms. Coenzyme Q0 regulates NFκB/AP-1 activation and enhances Nrf2 stabilization in attenuation of inflammation and redox imbalance. Coenzyme Q0 has anti-angiogenic activity through downregulation of MMP-9/NF-κB and upregulation of HO-1 signaling .

Coenzyme Q0

2 Publications Verification

CoQ0

Biochemical Assay Reagents

Coenzyme Q0 (CoQ0) is a potent, oral active ubiquinone compound can be derived from Antrodia cinnamomea. Coenzyme Q0 induces apoptosis and autophagy, suppresses of HER-2/AKT/mTOR signaling to potentiate the apoptosis and autophagy mechanisms. Coenzyme Q0 regulates NFκB/AP-1 activation and enhances Nrf2 stabilization in attenuation of inflammation and redox imbalance. Coenzyme Q0 has anti-angiogenic activity through downregulation of MMP-9/NF-κB and upregulation of HO-1 signaling .

HY-119976R

Boscalid (Standard)	Biochemical Assay Reagents
Boscalid (Standard) is the analytical standard of Boscalid. This product is intended for research and analytical applications. Boscalid is a succinate dehydrogenase (SDHI) inhibitor with antifungal activity. Boscalid binds to the ubiquinone-binding site of fungal mitochondrial complex II, blocks ATP production and aerobic respiration, exhibits good control efficacy against a variety of plant fungal diseases including gray mold, sclerotinia rot and powdery mildew, and is widely used for disease control in agriculture. Boscalid induces apoptosis, altered lipid metabolism, mitochondrial dysfunction, respiratory impairment, oxidative stress, ROS accumulation and neurodevelopmental disorders in zebrafish. Boscalid reduces foraging ability, shortens median death time and causes chronic toxicity in exposed honeybees. Boscalid also possesses genotoxicity, cytotoxicity, elevated mitochondrial superoxide levels and early-stage apoptosis .

Boscalid (Standard)

Biochemical Assay Reagents

Boscalid (Standard) is the analytical standard of Boscalid. This product is intended for research and analytical applications. Boscalid is a succinate dehydrogenase (SDHI) inhibitor with antifungal activity. Boscalid binds to the ubiquinone-binding site of fungal mitochondrial complex II, blocks ATP production and aerobic respiration, exhibits good control efficacy against a variety of plant fungal diseases including gray mold, sclerotinia rot and powdery mildew, and is widely used for disease control in agriculture. Boscalid induces apoptosis, altered lipid metabolism, mitochondrial dysfunction, respiratory impairment, oxidative stress, ROS accumulation and neurodevelopmental disorders in zebrafish. Boscalid reduces foraging ability, shortens median death time and causes chronic toxicity in exposed honeybees. Boscalid also possesses genotoxicity, cytotoxicity, elevated mitochondrial superoxide levels and early-stage apoptosis .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N0111

Coenzyme Q10 Maximum Cited Publications 14 Publications Verification CoQ10; Ubiquinone-10; Ubidecarenone	Neurological Disease Classification of Application Fields Anti-aging Metabolic Disease Endogenous metabolite Quinones Human Gut Microbiota Metabolites Microorganisms Benzene Quinones Inflammation/Immunology Disease Research Fields Source Classification Cancer	Endogenous Metabolite Reactive Oxygen Species (ROS) Ferroptosis
Coenzyme Q10 is an essential cofactor of the electron transport chain and a potent antioxidant agent.

HY-113449

Ubiquinone-1	Quinones Human Gut Microbiota Metabolites Immune System Disorder Microorganisms Classification of Application Fields Disease markers Other Diseases Benzene Quinones Nervous System Disorder Endogenous metabolite Disease Research Fields Source Classification	Endogenous Metabolite NADPH Oxidase
Ubiquinone-1 is an intermediate in the synthesis of Coenzyme Q. Ubiquinone-1 can be reduced by NADPH oxidase, hepatoma cells, Ascorbic acid (HY-B0166) .

HY-101415

Coenzyme Q9 1 Publications Verification Ubiquinone Q9; CoQ9; Ubiquinone 9	Cardiovascular Disease Quinones Microorganisms Classification of Application Fields Benzene Quinones Endogenous metabolite Disease Research Fields Source Classification	Apoptosis Endogenous Metabolite
Coenzyme Q9 (Ubiquinone Q9), the major form of ubiquinone in rodents, is an amphipathic molecular component of the electron transport chain that functions as an endogenous antioxidant. Coenzyme Q9 attenuates the diabetes-induced decreases in antioxidant defense mechanisms. Coenzyme Q9 improves left ventricular performance and reduces myocardial infarct size and cardiomyocyte apoptosis .

HY-113037C

Farnesyl pyrophosphate ammonium Farnesyl diphosphate ammonium	Natural Products Neurological Disease Classification of Application Fields Endogenous metabolite Disease Research Fields Source Classification	TRP Channel Endogenous Metabolite Calcium Channel
Farnesyl pyrophosphate (Farnesyl diphosphate) ammonium is a metabolic intermediate in the mevalonate (MVA) pathway. It is a TRP channel (TRPM2) agonist that triggers Ca2+ influx and cell death. Farnesyl pyrophosphate ammonium is a key branch substrate for cholesterol synthesis, ubiquinone synthesis, protein farnesylation, and geranylgeranyl pyrophosphate (GGPP) synthesis. Farnesyl pyrophosphate ammonium is used in research on cerebral ischemia, neurodegenerative diseases, pancreatic cancer, inflammation, and autoimmune diseases .

HY-114936

Piericidin A 5 Publications Verification AR-054	Infection Microorganisms Neurological Disease Classification of Application Fields Antibiotics Anti-parasitic Antibacterial Disease Research Anticancer Disease Research Fields Other Antibiotics Source Classification	Bacterial ADC Payload Antibiotic Mitochondrial Metabolism
Piericidin A (AR-054) is a natural mitochondrial *NADH-ubiquinone* oxidoreductase (complex I) inhibitor. Piericidin A is a potent neurotoxin and inhibits mitochondrial respiration by disrupting the electron transport system through its action on NADH-ubiquinone reductase. Piericidin A is also a potential quorum-sensing** inhibitor that suppresses the expression of the virulence genes of Erwinia carotovora subsp. atroseptica (Eca). Piericidin A is an ADC cytotoxin and has anti-bacterial, anticancer, insecticidal activity .

HY-113037

(E/Z)-Farnesyl pyrophosphate (E/Z)-Farnesyl diphosphate	Structural Classification Natural Products Human Gut Microbiota Metabolites Microorganisms Neurological Disease Classification of Application Fields Endogenous metabolite Disease Research Fields Source Classification	TRP Channel Endogenous Metabolite
(E/Z)-Farnesyl pyrophosphate ((E/Z)-Farnesyl diphosphate), a 15-carbon isoprenoid, is a metabolic intermediate of the mevalonate (MVA) pathway. (E/Z)-Farnesyl pyrophosphate is a TRPM2 (TRP Channel) agonist, activates TRPM2 opening for ion influx. (E/Z)-Farnesyl pyrophosphate is a key branch substrate for cholesterol synthesis, ubiquinones synthesis, protein farnesylation decoration, and geranyl-geranyl pyrophosphate (GGPP) synthesis .

HY-129605

Ferulenol	Infection other families Classification of Application Fields Coumarins Phenylpropanoids Plants Disease Research Fields Source Classification	Oxidative Phosphorylation Mitochondrial Metabolism
Ferulenol, a sesquiterpene prenylated coumarin derivative, specifically inhibits succinate ubiquinone reductase at the level of the ubiquinonecycle. Ferulenol shows good antimycobacterial activity and haemorrhagic action .

HY-N0111R

Coenzyme Q10 (Standard) CoQ10 (Standard); Ubiquinone-10 (Standard); Ubidecarenone (Standard)	Quinones Structural Classification Human Gut Microbiota Metabolites Microorganisms Benzene Quinones Endogenous metabolite Source Classification	Reference Standards Endogenous Metabolite Reactive Oxygen Species (ROS) Ferroptosis
Coenzyme Q10 (Standard) is the analytical standard of Coenzyme Q10. This product is intended for research and analytical applications. Coenzyme Q10 is an essential cofactor of the electron transport chain and a potent antioxidant agent.

HY-101415R

Coenzyme Q9 (Standard) Ubiquinone Q9 (Standard); CoQ9 (Standard); Ubiquinone 9 (Standard)	Quinones Structural Classification Microorganisms Benzene Quinones Endogenous metabolite Source Classification	Reference Standards Apoptosis Endogenous Metabolite
Coenzyme Q9 (Standard) is the analytical standard of Coenzyme Q9. This product is intended for research and analytical applications. Coenzyme Q9 (Ubiquinone Q9), the major form of ubiquinone in rodents, is an amphipathic molecular component of the electron transport chain that functions as an endogenous antioxidant. Coenzyme Q9 attenuates the diabetes-induced decreases in antioxidant defense mechanisms. Coenzyme Q9 improves left ventricular performance and reduces myocardial infarct size and cardiomyocyte apoptosis .

HY-N9610

Coenzyme Q6 Ubiquinone 30	Quinones Microorganisms Benzene Quinones Source Classification	Endogenous Metabolite
Coenzyme Q6 (Ubiquinone 30) is an isoprenylated benzoquinone lipid. Coenzyme Q6 exhibits functions in respiratory electron transport and as a lipid antioxidant. Coenzyme Q6 also has antioxidant effects, which can prevent the production of free radicals and oxidative damage .

HY-N9680

Coenzyme Q8 Ubiquinone 8	Quinones Structural Classification Leguminosae Pisum sativum Linn Benzene Quinones Plants Source Classification	Endogenous Metabolite Bacterial
Coenzyme Q8 (Ubiquinone 8) is an isoprenoid quinone that mediates electron transfer within the aerobic respiratory chain and reduces oxidative stress. Coenzyme Q8 maintains bacterial respiratory function and enhances host resistance to bacterial infection. Coenzyme Q8 stimulates macrophage phagocytosis and increases antibody-producing cells. Coenzyme Q8 can be used in infectious disease research .

HY-N11884

Ubiquinone Q3	Quinones Structural Classification Microorganisms Benzene Quinones Endogenous metabolite Source Classification	Endogenous Metabolite
Ubiquinone Q3 is an isoprenoid-chain ubiquinone homologue found in Saccharomyces cerevisiae, Escherichia coli, and Rhodospirillum rubrum. Ubiquinone Q3 has antioxidant activity and traps lipid peroxyl radicals .

HY-146036

NADH-IN-1	Natural Products Classification of Application Fields Metabolic Disease Endogenous metabolite Disease Research Fields Source Classification	Endogenous Metabolite
NADH-IN-1 has *NADH:ubiquinone* oxidoreductase inhibitory activity with an IC₅₀** value of 27 μM. NADH-IN-1 can effectively stimulate glucose uptake in vitro. NADH-IN-1 is readily metabolised by the liver. NADH-IN-1 can be used for researching diabetes .

Species:	Human (2)
Tag:	His (2) Fc (1)
Source:	HEK293 (1) E. coli (1)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P704801

	SDHA Protein, Human (His) Succinate dehydrogenase [Ubiquinone] flavoprotein subunit, mitochondrial; SDHA; Flavoprotein subunit of complex II (Fp); Malate dehydrogenase [quinone] flavoprotein subunit;	Human	E. coli
	SDHA Protein, Human (His) is the recombinant human-derived SDHA protein, expressed by E. coli, with C-6*His tag.

HY-P70096

	COQ7 Protein, Human (HEK293, His) rHu5-demethoxyUbiquinone hydroxylase, mitochondrial/COQ7, His; Ubiquinone Biosynthesis Protein COQ7 Homolog; Coenzyme Q Biosynthesis Protein 7 Homolog; Timing Protein Clk-1 Homolog; COQ7	Human	HEK293
	The COQ7 protein is a key enzyme in lipid A biosynthesis and catalyzes a key hydrolysis step involving UDP-3-O-myristoyl-N-acetylglucosamine. This activity leads to the formation of UDP-3-O-myristoylglucosamine and acetate, which is a decisive point in lipid A synthesis. COQ7 Protein, Human (HEK293, His) is the recombinant human-derived COQ7 protein, expressed by HEK293 , with C-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-N0111S2

Coenzyme Q10-d9
Coenzyme Q10-d₉ is the deuterium labeled Coenzyme Q10. Coenzyme Q10 is an essential cofactor of the electron transport chain and a potent antioxidant agent.

HY-N0111S

Coenzyme Q10-d6
Coenzyme Q10-d₆ is deuterium labeled Coenzyme Q10. Coenzyme Q10 is an essential cofactor of the electron transport chain and a potent antioxidant agent.

HY-113037CS

Farnesyl pyrophosphate-d2 triammonium

Farnesyl pyrophosphate-d₂ (Farnesyl diphosphate-d₂) triammonium is a deuterium labeled Farnesyl pyrophosphate triammonium (HY-113037C). Farnesyl pyrophosphate ammonium is a metabolic intermediate in the mevalonate (MVA) pathway. It is a TRP channel (TRPM2) agonist that triggers Ca2+ influx and cell death. Farnesyl pyrophosphate ammonium is a key branch substrate for cholesterol synthesis, ubiquinone synthesis, protein farnesylation, and geranylgeranyl pyrophosphate (GGPP) synthesis. Farnesyl pyrophosphate ammonium is used in research on cerebral ischemia, neurodegenerative diseases, pancreatic cancer, inflammation, and autoimmune diseases.

HY-113037AS

Farnesyl pyrophosphate-d6

Farnesyl pyrophosphate-d₆ (Farnesyl diphosphate-d₆) is a deuterium labeled Farnesyl pyrophosphate (HY-113037B). Farnesyl pyrophosphate is a metabolic intermediate in the mevalonate (MVA) pathway. It is a TRP channel (TRPM2) agonist that triggers Ca2+ influx and cell death. Farnesyl pyrophosphate is a key branch substrate for cholesterol synthesis, ubiquinone synthesis, protein farnesylation, and geranylgeranyl pyrophosphate (GGPP) synthesis. Farnesyl pyrophosphate is used in research on cerebral ischemia, neurodegenerative diseases, pancreatic cancer, inflammation, and autoimmune diseases.

HY-119976S

Boscalid-d4

Boscalid-d₄ is the deuterium labeled Boscalid. Boscalid is a succinate dehydrogenase (SDHI) inhibitor with antifungal activity. Boscalid binds to the ubiquinone-binding site of fungal mitochondrial complex II, blocks ATP production and aerobic respiration, exhibits good control efficacy against a variety of plant fungal diseases including gray mold, sclerotinia rot and powdery mildew, and is widely used for disease control in agriculture. Boscalid induces apoptosis, altered lipid metabolism, mitochondrial dysfunction, respiratory impairment, oxidative stress, ROS accumulation and neurodevelopmental disorders in zebrafish. Boscalid reduces foraging ability, shortens median death time and causes chronic toxicity in exposed honeybees. Boscalid also possesses genotoxicity, cytotoxicity, elevated mitochondrial superoxide levels and early-stage apoptosis .

Host:	Rabbit (19)
Reactivity:	Human (19) Rat (17) Mouse (18) Monkey (1)
Application:	IHC-P (16) ICC/IF (12) IP (14) IHC-F (4) WB (19) FC (5) ELISA (4)
Isotype:	IgG (18) IgG/Kappa (1)
Conjugation:	Non-conjugated (19)
Clonality:	Monoclonal (16) Recombinant (11)
Modification:	Unmodified (16)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P81585

	NDUFB10 Antibody (YA1330) NDUFB10; NADH dehydrogenase [Ubiquinone] 1 beta subcomplex subunit 10; Complex I-PDSW; CI-PDSW; NADH-Ubiquinone oxidoreductase PDSW subunit	WB, IHC-F, IHC-P, ICC/IF, FC, IP	Human, Mouse, Rat
	NDUFB10 Antibody (YA1330) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFB10.

HY-P86291

	NDUFA1 Antibody (YA5983) NDUFA1; NADH dehydrogenase [Ubiquinone] 1 alpha subcomplex subunit 1 ; Complex I-MWFE; CI-MWFE; NADH-Ubiquinone oxidoreductase MWFE subunit;	WB, IHC-P, IP	Human
	NDUFA1 Antibody (YA5983) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFA1.

HY-P81585A

	NDUFB10 Antibody (YA1330)(PBS only) NDUFB10; NADH dehydrogenase [Ubiquinone] 1 beta subcomplex subunit 10; Complex I-PDSW; CI-PDSW; NADH-Ubiquinone oxidoreductase PDSW subunit	WB, IHC-F, IHC-P, ICC/IF, FC, IP	Human, Mouse, Rat
	NDUFB10 Antibody (YA1330) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFB10.

HY-P86493

	NDUFB8 Antibody (YA6185) ASHI antibody; CI-ASHI antibody; Complex I ASHI subunit antibody; Complex I-ASHI antibody; mitochondrial antibody; NADH dehydrogenase (Ubiquinone) 1 beta subcomplex 8 19kDa antibody; NADH dehydrogenase [Ubiquinone] 1 beta subcomplex subunit 8 antibody; NADH-Ubiquinone oxidoreductase ASHI subunit antibody; NDUB8_HUMAN antibody; NDUFB8 antibody	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	NDUFB8 Antibody (YA6185) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFB8.

HY-P86984

	NDUFV2 Antibody (YA6677) 24kDa subunit of Complex I antibody; CI-24k antibody; complex I 24kDa subunit antibody; complex I, mitochondrial respiratory 2 antibody; mitochondrial antibody; NADH dehydrogenase (Ubiquinone) flavoprotein 2 antibody; NADH dehydrogenase (Ubiquinone) flavoprotein 2, 24kDa antibody; NADH dehydrogenase [Ubiquinone] flavoprotein 2 antibody; NADH dehydrogenase [Ubiquinone] flavoprotein 2, mitochondrial antibody; NADH Ubiquinone oxidoreductase 24 kDa subunit antibody; 24kDa subunit of Complex I antibody; CI-24k antibody; complex I 24kDa subunit antibody; complex I, mitochondrial respiratory 2 antibody; mitochondrial antibody; NADH dehydrogenase (Ubiquinone) flavoprotein 2 antibody; NADH dehydrogenase (Ubiquinone) flavoprotein 2, 24kDa antibody; NADH dehydrogenase [Ubiquinone] flavoprotein 2 antibody; NADH dehydrogenase [Ubiquinone] flavoprotein 2, mitochondrial antibody; NADH Ubiquinone oxidoreductase 24 kDa subunit antibody; NADH-Ubiquinone oxidoreductase 24 kDa subunit antibody; NADH-Ubiquinone oxidoreductase flavoprotein 2 antibody; NDUFV2 antibody; NDUV2_HUMAN antibody; nuclear-encoded mitochondrial NADH-Ubiquinone reductase 24Kd subunit antibody; Ubiquinoneflavoprotein 2 antibody; Ubiquinoneflavoprotein 2, mitochondrial precursor antibody;	WB, IHC-P, ICC/IF	Human, Mouse, Rat
	NDUFV2 Antibody (YA6677) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFV2.

HY-P87265

	NDUFA9 Antibody (YA6948) CI-39kD antibody; Complex I subunit NDUFA9 antibody; Complex I-39kD antibody; mitochondrial antibody; NADH dehydrogenase [Ubiquinone] 1 alpha subcomplex subunit 9 antibody; NADH dehydrogenase [Ubiquinone] 1 alpha subcomplex subunit 9 mitochondrial antibody; NADH Ubiquinone Oxidoreductase 1 alpha subcomplex 9 antibody; NADH-Ubiquinone oxidoreductase 39 kDa subunit antibody; NDUA9_HUMAN antibody; NDUFA9 antibody	WB, IP	Human, Mouse, Rat, Monkey
	NDUFA9 Antibody (YA6948) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFA9.

HY-P81595

	NDUFB9 Antibody (YA1340) NDUFB9; LYRM3; UQOR22; NADH dehydrogenase [Ubiquinone] 1 beta subcomplex subunit 9; Complex I-B22; CI-B22; LYR motif-containing protein 3; NADH-Ubiquinone oxidoreductase B22 subunit	WB, IHC-F, IHC-P, ICC/IF, IP	Human, Mouse, Rat
	NDUFB9 Antibody (YA1340) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFB9.

HY-P81595A

	NDUFB9 Antibody (YA1340)(PBS only) NDUFB9; LYRM3; UQOR22; NADH dehydrogenase [Ubiquinone] 1 beta subcomplex subunit 9; Complex I-B22; CI-B22; LYR motif-containing protein 3; NADH-Ubiquinone oxidoreductase B22 subunit	WB, IHC-F, IHC-P, ICC/IF, IP	Human, Mouse, Rat
	NDUFB9 Antibody (YA1340) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFB9.

HY-P86511

	NDUFS3 Antibody (YA6203) NDUFS3; NADH dehydrogenase [Ubiquinone] iron-sulfur protein 3; mitochondrial; Complex I-30kD; CI-30kD; NADH-Ubiquinone oxidoreductase 30 kDa subunit	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	NDUFS3 Antibody (YA6203) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFS3.

HY-P81601

	NDUFS3 Antibody (YA1346) NDUFS3; NADH dehydrogenase [Ubiquinone] iron-sulfur protein 3; mitochondrial; Complex I-30kD; CI-30kD; NADH-Ubiquinone oxidoreductase 30 kDa subunit	WB	Human, Mouse
	NDUFS3 Antibody (YA1346) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFS3.

HY-P86983

	NDUFAB1 Antibody (YA6676) ACP antibody; ACPM_HUMAN antibody; Acyl carrier protein antibody; Acyl carrier protein mitochondrial antibody; CI SDAP antibody; CI-SDAP antibody; FASN 2A antibody; FASN2A antibody; MGC65095 antibody; Mitochondrial acyl carrier protein antibody; ACP antibody; ACPM_HUMAN antibody; Acyl carrier protein antibody; Acyl carrier protein mitochondrial antibody; CI SDAP antibody; CI-SDAP antibody; FASN 2A antibody; FASN2A antibody; MGC65095 antibody; Mitochondrial acyl carrier protein antibody; mitochondrial antibody; NADH dehydrogenase (Ubiquinone) 1 alpha/beta subcomplex 1 8kDa antibody; NADH dehydrogenase (Ubiquinone) 1 alpha/beta subcomplex 1 antibody; NADH Ubiquinone oxidoreductase 9.6 kDa subunit antibody; NADH Ubiquinone oxidoreductase SDAP subunit antibody; NADH-Ubiquinone oxidoreductase 9.6 kDa subunit antibody; NDUFAB 1 antibody; ndufab1 antibody; SDAP antibody;	WB, IHC-P, FC	Human, Mouse, Rat
	NDUFAB1 Antibody (YA6676) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFAB1.

HY-P83352

	NDUFS2 Antibody (YA3097) NADH dehydrogenase (Ubiquinone) Fe-S protein 2; 49kDa; CI-49	WB, IHC-P, ICC/IF, IP	Human, Mouse, Rat
	NDUFS2 Antibody (YA3097) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFS2.

HY-P86640

	SDHA Antibody (YA6332) SDHA; SDH2; SDHF; Succinate dehydrogenase [Ubiquinone] flavoprotein subunit; mitochondrial; Flavoprotein subunit of complex II; Fp	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	SDHA Antibody (YA6332) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to SDHA.

HY-P83352A

	NDUFS2 Antibody (YA3097)(PBS only) NADH dehydrogenase (Ubiquinone) Fe-S protein 2; 49kDa; CI-49	WB, IHC-P, ICC/IF, IP	Human, Mouse, Rat
	NDUFS2 Antibody (YA3097) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFS2.

HY-P81835

	SDHB Antibody (YA1580) SDHB; SDH; SDH1; Succinate dehydrogenase [Ubiquinone] iron-sulfur subunit; mitochondrial; Iron-sulfur subunit of complex II; Ip	WB, IHC-P, IP, FC	Human, Mouse, Rat
	SDHB Antibody (YA1580) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to SDHB.

HY-P86391

	SDHB Antibody (YA6083) SDHB; SDH; SDH1; Succinate dehydrogenase [Ubiquinone] iron-sulfur subunit, mitochondrial; Iron-sulfur subunit of complex II; Ip	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	SDHB Antibody (YA6083) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to SDHB.

HY-P82790

	NDUFS1 Antibody (YA2535) NDUFS1; NADH-Ubiquinone oxidoreductase 75 kDa subunit; mitochondrial; Complex I-75kD; CI-75kD	WB, IHC-P, ICC/IF, IP, FC	Human, Mouse, Rat
	NDUFS1 Antibody (YA2535) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NDUFS1.

HY-P82344

	MT ND1 Antibody (YA2089) 2 Publications Verification MT-ND1; MTND1; NADH1; ND1; NADH-Ubiquinone oxidoreductase chain 1; NADH dehydrogenase subunit 1	WB	Human, Mouse, Rat
	MT ND1 Antibody (YA2089) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to MT ND1.

HY-P87067

	SDHC Antibody(YA6760) CYB560 antibody; C560_HUMAN antibody; CYBL antibody; Cytochrome B large subunit of complex II antibody; Integral membrane protein CII-3 antibody; mitochondrial antibody; PGL3 antibody; QPs-1 antibody; QPs1 antibody; SDH3 antibody; CYB560 antibody; C560_HUMAN antibody; CYBL antibody; Cytochrome B large subunit of complex II antibody; Integral membrane protein CII-3 antibody; mitochondrial antibody; PGL3 antibody; QPs-1 antibody; QPs1 antibody; SDH3 antibody; sdhC antibody; succinate dehydrgenase cytochrome b antibody; succinate dehydrogenase 3, integral membrane subunit antibody; Succinate dehydrogenase complex subunit C antibody; Succinate dehydrogenase complex subunit C integral membrane protein 15kDa antibody; Succinate dehydrogenase cytochrome b560 subunit antibody; Succinate dehydrogenase cytochrome b560 subunit mitochondrial antibody; Succinate dehydrogenase cytochrome b560 subunit, mitochondrial precursor antibody; Succinate-Ubiquinone oxidoreductase cytochrome B large subunit antibody;	WB, IHC-P	Human, Mouse, Rat
	SDHC Antibody(YA6760) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to SDHC.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Ubiquinone

Inhibitors & Agonists

Biochemical Assay Reagents

NaturalProducts

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Natural
Products